2012年北京市医疗机构制剂注册申请概况及申报中应关注的若干问题

来源 :首都医药 | 被引量 : 0次 | 上传用户:limutou
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的总结并分析2012年北京市医疗机构制剂注册申请概况及申报中应关注的若干问题,旨在提出一些制剂申报过程中应关注的事项,以供制剂注册申请人参考。方法通过对2012年北京市医疗机构制剂的申报情况进行汇总,同时与往年的数据进行比较和分析,针对北京市医疗机构制剂注册申请及申报具体过程中遇到的实际问题,提出制剂申请过程中的注意事项。结果通过对近几年申报的医疗机构制剂注册申请及申报的汇总及分析,发现存在一些不符合国家食品药品监督管理局《医疗机构制剂注册管理办法》(试行)和北京市药品监督管理局制定的《北京市医疗机构制剂注册管理办法实施细则》(试行)中要求的共性问题,需要提请申请人予以关注,以免影响申报进程。这些共性问题主要包括以下几方面:医疗机构化学药品制剂原料药的要求、中药饮片入药检验的要求、中药制剂功能主治书写应规范、制剂规范和包装规格的要求、延长有效期的补充申请的要求和关于医疗机构制剂价格的管理规定等。结论医疗机构制剂是指医疗机构根据本单位的临床需要并经有关部门批准而配制、自用的固定处方制剂,因其应是市场上没有供应的制剂品种,因此该种制剂注册申请及申报中遇到的问题更应该引起申报单位或个人的注意,以免影响其正常注册及申报。 OBJECTIVE To summarize and analyze some issues that should be paid attention to during the application and registration of preparations registration in medical institutions in 2012 in order to put forward some issues that should be paid attention to in the process of declaration of preparations for the reference of applicants for registration of preparations. Methods By summarizing the report of the preparation of medical institutions in Beijing in 2012 and comparing with the data of previous years, aiming at the actual problems encountered in the process of application registration and declaration in Beijing medical institutions, Precautions. Results Through the compilation and analysis of the applications for registration of preparations of medical institutions in recent years and the analysis of their declarations, there were some cases that did not meet the requirements of the Measures for the Administration of Registration of Pharmaceutical Preparations (Trial) of the State Food and Drug Administration and the Beijing Municipal Drug Administration Of the “Beijing Medical Institutions Registration Regulations” (Trial Implementation) requirements of common problems, need to be brought to the attention of applicants, so as not to affect the reporting process. These common issues mainly include the following aspects: the requirements of the pharmaceutical raw materials of medical institutions, the requirements for the testing of Chinese medicinal herbs, the specification of the main indications of Chinese medicinal preparations, the requirements of formulation specifications and packaging specifications, the requirements for extending supplementary medicinal products Medical institutions on the preparation of the price regulations. Conclusion The preparation of medical institutions refers to the fixed prescriptions prepared by medical institutions according to the clinical needs of the unit and approved by the relevant departments and used for personal use because they should not be supplied on the market. Therefore, To the issue should even cause the reporting unit or individual attention, so as not to affect their normal registration and reporting.
其他文献
提出了一种三维药柱燃面自动化设计的新方法:根据设计者输入的设计指标和全局参数值,自动确定一系列药柱结构可选方案,自动对每一个结构方案进行药形几何参数的优化设计,自动对结
从工程实际的角度,介绍了单燃速单室双推力三维药柱的设计方法和药型参数优化方法,并通过设计实例纠正了长期以来对以单一推进剂实现两级推力的几个认识误区,为这一新技术成果的
研究了七(2,6-二-O-羧甲基)-β-环糊精(羧甲基-β-CD和七{2,6-二-O[3-(1,3-二羧基丙氨基)-2-羟丙基]}-β-环糊精(谷氨酸-β-CD)两种水溶性环糊精衍生物的合成及在毛细管电泳
为采用联产新技术加快湿法磷酸(WPA)替代热法磷酸(TPA)生产磷酸盐的力度,对热法磷酸、化学法净化磷酸和溶剂法净化磷酸(PPA)及其深加工为化肥、磷酸氢钙和磷酸盐的成本和经济效益进
To investigate anti-tumor effect of bufalin on the orthotopic transplantation tumor model of humanhepatocellular carcinoma in nude mice. Methods: BEL-7402 cells
目的探讨本科室采用哮喘管理对支气管哮喘临床缓解期患儿治疗中作用.方法将儿科门诊158例支气管哮喘患儿分为哮喘管理指导组(试验组)和非指导组(对照组),对比两组哮喘患儿哮
目的:总结肝硬化病人的护理体会.方法:对51例肝硬化病人密切观察病情,和对护理资料进行分析.结果:51例病人,好转44例,自动出院2例,死亡5例.结论:通过密切观察肝硬化病人病情
目的本文探讨急性坏死性胰腺炎多器官损伤机制,并对防治ANP的全身炎症反应综合征和多器官功能障碍综合征及其治疗策略进行研究.方法经胰胆管逆行注射3.5%牛磺胆酸钠2.5?ml/kg